The fourth-quarter earnings season for the biotech sector is in full swing this week. A few bigwigs have already reported results. Among these, Bristol Myers reported better-than-expected ...

Gilead Sciences has battled back from a pipeline disappointment last year to its highest stock price in nearly a decade.

Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.

Shares of Gilead Sciences ( GILD 7.46%) were jumping 7.9% higher on Wednesday at 11:34 a.m. The solid gain came after the big ...

CRISPR Therapeutics AG (CRSP) stock jumped over 9% this week after delivering strong Q4 2024 results ahead of schedule. The headline numbers ...

Let's look at five pharma and drug companies, MRK PFE, LLY, AMGN and BMY, which are scheduled to release their fourth-quarter ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...

Shares of Incyte (INCY) fell 6% Monday after the company released its Q4 earnings report and 2025 sales forecast. Read more ...

The pain was most felt by smaller biotechnology companies whose earnings are often expected to materialize far into the future. This strategy’s overweighting in that bucket hurt, and it has ...

The sector primarily comprises pharma/biotech and medical device companies. See the Zacks Earnings Calendar to stay ahead of market-making news. The earnings season for the medical sector kicked ...